P3 Health Partners Inc. (PIIIW) stock

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30

$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

P3 Health Partners price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

P3 Health Partners's price to sales ratio was 0.0× on Oct 19, 2026, against 0.0× a year earlier. Over the last 4 years it ranged from 0.0× to 0.2×, with a median of 0.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	0.0×	+0.0
2025	Dec 31, 2025	0.0×	−0.0
2024	Dec 31, 2024	0.0×	−0.1
2023	Dec 29, 2023	0.2×	–

Where these numbers come from

Parsed from the XBRL in P3 Health Partners's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Apr 14, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PIIIW.

Compare: PIIIW vs PRVA · PIIIW vs INNV · PIIIW vs PNTG · PIIIW vs LFST · PIIIW vs DCGO

Revenue growth2.8% · median 20.4%

Operating margin-9.9% · median 1.9%

Net margin-6.6% · median 1.2%

Company	Revenue	Growth
PRVA	$2.36B	+24.1%
LFST	$1.58B	+20.4%
PIIIW	$1.50B	+2.8%
PNTG	$1.10B	+37.9%
INNV	$989.71M	+15.9%
DCGO	$294.72M	-32.4%

Company

Next earnings (est.): Nov 13, 2026, after close
Exchange: Nasdaq
Industry: Services-Health Services
Fiscal year ends: December 31
Employees: 320
Auditor: BDO USA, P.C.
SEC CIK: 1832511

Advertisement
300 × 250

P3 Health Partners price to sales ratio

Price to Sales Ratio at the end of each year

More P3 Health Partners figures